beta

You're viewing our new website - find out more

Publication - Consultation Paper

Review of Upper GI Cancer Quality Performance Indicators Consultation

Published: 16 Dec 2016
Part of:
Health and social care
ISBN:
9781786527028

Inviting views on the revised upper gastrointestinal (GI) cancer Quality Performance Indicators (QPIs).

37 page PDF

599.2kB

37 page PDF

599.2kB

Contents
Review of Upper GI Cancer Quality Performance Indicators Consultation
Footnotes

37 page PDF

599.2kB

Footnotes

a. Patients may undergo endoscopies which are not related to their cancer diagnosis therefore within the measurement of this QPI the 'initial endoscopy and biopsy' will be identified if no endoscopy occurred within the previous year.

b. TNM classification is a system for staging the extent of cancer. T describes the size of the tumour. N refers to the involvement of the lymph nodes. M refers to the presence of metastatic disease.

c. Patients presenting with stage TxNxM 1 disease have metastatic cancer where the extent of primary tumour or lymph node involvement cannot be assessed.

d. Oncological treatments included are as follows:

Curative:

  • Chemoradiotherapy
  • Peri-operative chemotherapy (this includes neo-adjuvant and adjuvant chemotherapy / chemoradiotherapy)

Palliative:

  • Chemotherapy

Contact